Press Releases
Provepharm obtains European marketing authorization for its Methylthioninium Chloride Proveblue
Provepharm, a biotech start-up specialized in the development of pharmaceutical applications, announces today that it has just received official marketing authorization for its Methylthioninium Chloride Proveblue from the European Medicines Agency. This authorization means that clinicians...
Press Releases
Sagent Pharmaceuticals Plans Launch of Piperacillin and Tazobactam, the Generic Form of Zosyn(R), for Injection
Sagent Pharmaceuticals, Inc. announced its planned launch of piperacillin and tazobactam for injection, the generic form of Zosyn®, in three distinct single dose vial forms. Piperacillin and tazobactam is used for the treatment of patients with moderate to severe...
Press Releases
Kodak Supports the Fight Against Counterfeit Pharmaceuticals
KODAK’s Security Solutions Group will attend the IQPC Anti-Counterfeiting for Pharma & Medical Devices seminar at The Chemical Heritage Foundation Conference Center in Philadelphia, Pa., May 31-June 2. Kodak’s participation includes a technology demonstration of its brand protection capabilities...
Press Releases
Cytheris and CITN announce selection of recombinant interleukin-7 (CYT107) for initial studies at member institutions
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, and the Cancer Immunotherapy Trials Network (CITN), a new initiative in immunotherapy funded by the National Cancer Institute with its Central...
Press Releases
Roche and Merck Establish Strategic Agreements in Fight Against Chronic Hepatitis C
Roche announced that it has entered into agreements with Merck, known as MSD outside the United States, through their respective subsidiaries, to improve the treatment, diagnosis and awareness of chronic hepatitis C (HCV) infection in the United States. The...
Press Releases
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes....
Press Releases
The American Society of Clinical Oncology and CollabRx Partner to Develop Online Apps for Planning Cancer Treatment
The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing physicians who care for people with cancer, and CollabRx, an organization that leverages information technology to personalize cancer treatments and accelerate research have forged a strategic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.